top of page

Beyond the Next Outbreak: Rethinking Vaccine Research Preparedness in Africa

12 October 2026

Preparedness is easy to talk about during a crisis. The harder question is what happens between crises.

 

That question sat at the heart of HKJCGHI's side meeting on 12 October 2026 at the World Health Summit 2026 in Berlin, which brought together researchers, public health leaders, funders and policymakers from across Africa, Asia and beyond to examine what vaccine research preparedness should look like in a world shaped by COVID-19, mpox, Ebola and Lassa fever.

 

Opening the meeting, Professor Ravi Gupta, Co-Director of HKJCGHI and The Hong Kong Jockey Club Professor of Global Health at the University of Cambridge, invited participants to think beyond emergency response. Drawing on HKJCGHI's work in vaccine research, pandemic preparedness, capacity building and Africa-Asia collaboration, he argued that preparedness is not merely about having the right technologies when an outbreak strikes. It is about building research ecosystems, nurturing partnerships and creating pathways through which knowledge, expertise and innovation can move quickly when they are needed most.

 

Offering a global perspective, Dr Richard Hatchett, Chief Executive Officer of the Coalition for Epidemic Preparedness Innovations (CEPI), described the Africa Research Preparedness Program, an Africa CDC-led initiative designed to establish a sustainable clinical research network across West Africa, with expansion planned for East and Central Africa. The programme seeks to transform preparedness from a project-based activity into a standing capability, one that can support routine vaccine research today while remaining ready to respond rapidly when the next outbreak emerges.

 

If Hatchett's presentation focused on what could be built, Prof Alash'le Abimiku, Executive Director of the International Research Center of Excellence (IRCE) at the Institute of Human Virology Nigeria (IHVN), offered a powerful example of what has already been built.

 

Drawing on the evolution of IHVN, she described how investments originally made to support HIV and tuberculosis programmes have gradually expanded into a broader platform encompassing clinical trials, genomic surveillance, laboratory science, biobanking, workforce development and pandemic preparedness. Her experience illustrated a theme that surfaced repeatedly throughout the meeting: the strongest systems are rarely created from scratch. More often, they emerge by strengthening existing institutions, connecting existing networks and building on foundations that already exist. She also highlighted practical challenges facing many research institutions, including infrastructure constraints, limited regulatory capacity and the need to build community trust to address vaccine hesitancy.

 

Together, the two presentations highlighted both the progress that has been made and the work that remains to strengthen research preparedness across Africa.

 

Moderated by Dr Jakob Cramer, Chief Medical Officer and Vice President, Clinical Development at Medicines for Malaria Venture (MMV), and Chair of the HKJCGHI Scientific Advisory Board, the conversation ranged well beyond vaccines.

 

Participants pointed to regulatory readiness, domestic financing, manufacturing capability, workforce development and community trust as equally important components of preparedness.

Many also observed that preparedness efforts remain vulnerable to a familiar cycle in which investment surges during emergencies, only to fade once the immediate threat has passed. Scientific innovation alone, many argued, is insufficient if it cannot be translated into products, policies and public confidence.

 

Again and again, the discussion returned to a common conclusion: preparedness is ultimately a systems challenge. It depends not only on laboratories and technologies, but also on institutions, partnerships and political commitment.

 

Another theme that emerged was the importance of keeping preparedness systems active between crises. Participants stressed that capabilities in research, surveillance and clinical trials must be maintained and connected in peacetime so they can be rapidly mobilised when needed.

 

If there was a note of optimism, it came from the recognition that many of those building blocks are already taking shape. Across Africa, centres of excellence are emerging, regional networks are strengthening, and new models of collaboration are beginning to connect research, policy and public health in ways that would have been difficult to imagine a decade ago.

 

The conversation is far from over. Participants looked ahead to upcoming convenings in Hong Kong, including the HKJCGHI Pandemic Preparedness Meeting (18-19 November 2026) and the World Health Summit Regional Meeting 2027 in Hong Kong, as opportunities to continue building momentum and deepen collaboration across regions.

 

The lasting message from Berlin was both simple and timely: preparedness is not something that can be stockpiled. It is something that must be built, sustained and renewed long before the next crisis begins. Across Africa, many of the foundations are already taking shape, from research networks and clinical trial platforms to surveillance systems and regional partnerships. The challenge now is not whether these building blocks exist, but whether the global community can invest in them consistently enough to realise their full potential. If it can, the next chapter in pandemic preparedness may be defined not by reacting to crises, but by being ready for them.

For any inquiries, please contact us via email: inquiry@hkjcghi.org

  • LinkedIn
  • X
  • Instagram
  • Facebook

Copyright © 2026. The Hong Kong Jockey Club Global Health Institute. All rights reserved.

bottom of page